Strengthen and accelerate your response
Improving global public health is critical, but what can be done to effectively manage the costs of development? How do you ensure that you’re meeting regulatory standards on a global basis? And, how do you quickly and safely get much-needed treatments into the hands of those who so desperately need them?
Get new treatments to market efficiently and cost-effectively
Quintiles can help minimize the obstacles to market and maximize the value of your new infectious disease treatments and microbial agents. More than 1,800 experienced infectious disease team members can deliver your clinical study with high quality results. You’ll benefit from:
- Rapid enrollment during peak illness seasons.
- Large, worldwide patient recruitment.
- Expert monitoring of lengthy, complex studies.
- Global regulatory compliance.
Quintiles has helped develop or commercialize 96% of 2013’s top 50 best-selling anti-infective products or compounds, and 100% of the top 15. In the past five years alone, we’ve provided clinical services for more than 260 infectious diseases (non-vaccine) studies involving over 168,000 subjects and 10,600 investigator sites in 87 countries.